மையம் க்கு மீளுருவாக்கம் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மையம் க்கு மீளுருவாக்கம் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மையம் க்கு மீளுருவாக்கம் மருந்து Today - Breaking & Trending Today

AKU wins Rs159 million grant to develop gene-editing therapies for blood disorders


July 1, 2021
Innovative gene-editing therapies for two significant blood disorders, beta thalassemia and sickle cell anaemia, have received a boost with the AKU’s Centre for Regenerative Medicine and Stem Cell Research, CRM, winning a competitive research grant of Rs159.60 million ($1.02 m) to look for a genetic ‘fix’.
Thalassemia and sickle cell disease are genetic disorders, passed down from parent to child, and are common in Pakistan. There are as many as 100,000 transfusion-dependent thalassemia patients in the country. Every year another 5,000 babies are born with the disorder. On the other hand, sickle-cell disease is one of the well-known causes of anaemia in Pakistan. ....

United States , United Kingdom , San Francisco , Afsar Mian , El Nasir Lalani , Mohammed Yusuf , Salma Jahan , Stem Cell Research , University Of California , Centre For Regenerative Medicine , Cardiff University , Norwegian University Of Science , Regenerative Medicine , Professor El Nasir Lalani , Drs Afsar Mian , Mohammad Hassan , Norwegian University , Challenge Fund , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , சான் பிரான்சிஸ்கோ , எல் நசீர் லலானி , முகமது யூசுப் , சல்மா ஜஹான் , தண்டு செல் ஆராய்ச்சி , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா ,

AKU wins grant to develop gene therapies for blood disorders - Newspaper


KARACHI: Efforts to find less-invasive and more affordable cure for two common genetic disorders beta thalassaemia and sickle cell anaemia have received a boost with Aga Khan University’s research centre recently winning a competitive research grant of Rs159.60 million.
Currently, Pakistan has an estimated 100,000 transfusion-dependent thalassaemia patients with 5,000 babies born with the disease every year.
On the other hand, sickle-cell disease is one of the well-known causes of anaemia in the country.
Doctors and research scientists are aware that mutations in the haemoglobin beta-globin, HBB gene causes both diseases. Patients suffer from a lack of haemoglobin, the protein that carries oxygen from the lungs to the rest of the body; and a lack of oxygen in the body’s tissues can lead to poor growth, organ damage and other health problems. ....

United States , United Kingdom , San Francisco , Afsar Mian , El Nasir Lalani , Mohammed Yusuf , Salma Jahan , University Of California , Stem Cell Research , Centre For Regenerative Medicine , Cardiff University , Aga Khan University , Norwegian University Of Science , Regenerative Medicine , Professor El Nasir Lalani , Drs Afsar Mian , Mohammad Hassan , Norwegian University , Challenge Fund , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , சான் பிரான்சிஸ்கோ , எல் நசீர் லலானி , முகமது யூசுப் , சல்மா ஜஹான் , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா ,